<DOC>
	<DOCNO>NCT00006259</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiation therapy may able deliver x-ray directly tumor cause less damage normal tissue . PURPOSE : Phase II trial study effectiveness stereotactic radiation therapy treat patient brain metastasis .</brief_summary>
	<brief_title>Stereotactic Radiation Therapy Treating Patients With Brain Metastases</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy stereotactic radiosurgery without whole brain radiotherapy elderly patient patient poor performance status brain metastasis . II . Determine neurologic function patient receive treatment regimen . III . Determine quality life patient treatment regimen . OUTLINE : Patients undergo stereotactic head frame placement , follow stereotactic radiosurgery use Gamma Knife , day 1 . Quality life assess one week prior one week treatment , 2 , 4 , 6 , 8 , 10 , 12 month . Patients follow one week , 2 , 4 , 6 , 8 , 10 , 12 month , every 4 month one year , every 6 month 3 year . PROJECTED ACCRUAL : Approximately 52 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients 14 site brain metastasis Confirmed MRI gadolinium texaphyrin scan within two week study If solitary metastasis , diameter must 40 mm less If multiple metastasis , one site may great 30 mm , others must less 30 mm No metastases brainstem within 5 mm optic nerve chiasm Prior surgical resection metastasis allow radiographically visible residual disease No prior cranial radiotherapy Patients must 65 year age OR Over 18 year age Karnofsky performance status 4060 % All primary histology allow except follow : Lymphomas Leukemia Multiple myeloma Small cell lung cancer Germ cell tumor Extracranial disease allow PATIENT CHARACTERISTICS : Age : See Disease Characteristics Performance status : See Disease Characteristics Life expectancy : Not specify Hematopoietic : Hemoglobin great 8 g/dL Absolute neutrophil count great 1,000/mm3 Platelet count great 50,000/mm3 Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Prior chemotherapy allow Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics Prior concurrent radiotherapy noncranial site allow Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>tumor metastatic brain</keyword>
</DOC>